Tokyo Tape
Sign in
← Oncolys BioPharma

Quarterly report · Q2

4588.TEDINET S100RJIV
Period2023-01-01 → 2023-06-30
Filed2023-08-04
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥63m2023-01-01 → 2023-06-30StandaloneNet sales
Revenue¥976m2022-01-01 → 2022-12-31StandaloneNet sales (5-year summary)
Revenue¥426m2022-01-01 → 2022-06-30StandaloneNet sales
Operating income−¥901m2023-01-01 → 2023-06-30StandaloneOperating income
Operating income−¥659m2022-01-01 → 2022-06-30StandaloneOperating income
Ordinary income−¥867m2023-01-01 → 2023-06-30StandaloneOrdinary income
Ordinary income−¥1.2bn2022-01-01 → 2022-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥591m2022-01-01 → 2022-06-30StandaloneOrdinary income
Profit before tax−¥867m2023-01-01 → 2023-06-30StandaloneIncome before income taxes
Profit before tax−¥569m2022-01-01 → 2022-06-30StandaloneIncome before income taxes
Net income−¥869m2023-01-01 → 2023-06-30StandaloneProfit loss
Net income−¥1.1bn2022-01-01 → 2022-12-31StandaloneNet income loss (5-year summary)
Net income−¥571m2022-01-01 → 2022-06-30StandaloneProfit loss
Total assets¥1.9bnat 2023-06-30StandaloneAssets
Total assets¥2.7bnat 2022-12-31StandaloneAssets
Total assets¥3.5bnat 2022-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥576mat 2023-06-30StandaloneLiabilities
Total liabilities¥492mat 2022-12-31StandaloneLiabilities
Net assets / equity¥1.3bnat 2023-06-30StandaloneNet assets
Net assets / equity¥2.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥2.7bnat 2022-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.3bnat 2023-06-30StandaloneCash and deposits
Cash and deposits¥1.7bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2023-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥2.6bnat 2022-06-30StandaloneCash and cash equivalents
Cash & equivalents¥3.2bnat 2021-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥452m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.7bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥722m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥748,0002023-01-01 → 2023-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow¥20m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥21m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥45m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥114m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥30m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-50.162023-01-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-31.472023-04-01 → 2023-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.312022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-32.922022-01-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-13.942022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio68.7%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio81.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.9%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued17,405,200at 2023-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2022-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 446
ItemContextValueUnit
Net assetsCurrentQuarterInstant_NonConsolidatedMember1290506000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember2650959000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember1866628000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember426152000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember63038000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember186697000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember32433000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember239454000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember30604000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember898353000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember931594000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-658898000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-900989000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember284000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember533000JPY
Dividends income noiPrior1YTDDuration_NonConsolidatedMember－JPY
Dividends income noiCurrentYTDDuration_NonConsolidatedMember3000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember84344000JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember35051000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember12000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember177000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember84641000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember35765000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember1937000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember1781000JPY
Amortization of restricted stock remuneration noePrior1YTDDuration_NonConsolidatedMember14289000JPY
Amortization of restricted stock remuneration noeCurrentYTDDuration_NonConsolidatedMember435000JPY
Stock issuance cost noePrior1YTDDuration_NonConsolidatedMember30000JPY
Stock issuance cost noeCurrentYTDDuration_NonConsolidatedMember－JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember16257000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember2217000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-590514000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-867441000JPY
Gain on sale of receivables eiPrior1YTDDuration_NonConsolidatedMember21406000JPY
Gain on sale of receivables eiCurrentYTDDuration_NonConsolidatedMember－JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration_NonConsolidatedMember－JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration_NonConsolidatedMember136000JPY
Extraordinary incomePrior1YTDDuration_NonConsolidatedMember21406000JPY
Extraordinary incomeCurrentYTDDuration_NonConsolidatedMember136000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-569108000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-867305000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember1461000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember1457000JPY
Income taxesPrior1YTDDuration_NonConsolidatedMember1461000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember1457000JPY
Profit lossPrior1YTDDuration_NonConsolidatedMember-570569000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember-868762000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-569108000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-867305000JPY
Depreciation and amortization ope cfPrior1YTDDuration_NonConsolidatedMember155000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-06-30pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-06-30pass